Wei Yan, Ph.D., President & CEO of Sound Biologics. Wei cofounded the company in 2015 and led the development of MabPair Technology. Under his leadership, Sound Biologics has successfully grown into a clinical stage company with a unique technology platform and robust pipeline. Wei has over 25 years of industry experience in developing antibody based biotherapeutics. Prior to founding Sound Biologics, he was Director of Antibody Technology at Amgen Seattle site. During his 14 year-tenure at Amgen and Immunex, Wei and his colleagues engineered many molecules in the pipeline and developed novel technologies that enable the production of bispecific antibodies, monovalent antibodies and antibodies with enhanced effector functions. Wei was co-inventor of more than 15 issued patents or patent applications. He received his B.S. degree from Peking University in China and Ph.D. in Molecular and Cell Biology from the joint program of Cornell University Medical College and Memorial Sloan Kettering Cancer Center.